You are here

Milestone Pharmaceuticals

Back to business for biotech flotations

EP Vantage

Wed, 07/3/19 - 09:48 am

Turning Point Therapeutics

Stoke Therapeutics

Prevail Therapeutics

NGM Biopharmaceuticals

Akero Therapeutics

Milestone Pharmaceuticals

Morphic Therapeutics

Two Days, Five Biotech IPOs, and $359M Raised for Clinical Trials

Xconomy

Thu, 05/9/19 - 11:06 am

clinical trials

Milestone Pharmaceuticals

Trevi Therapeutics

Four biotech Nasdaq wannabes outline IPO plans — and don't miss Chi-Med's HKEX pitch

Endpoints

Mon, 04/15/19 - 12:11 pm

Applied Therapeutics

Milestone Pharmaceuticals